Skip to main content
Michaela Liedtke, MD, Hematology, Stanford, CA

MichaelaLiedtkeMD

Hematology Stanford, CA

Assistant Professor, Medicine - Hematology, Stanford University Medical Center

Dr. Liedtke is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Liedtke's full profile

Already have an account?

  • Office

    300 Pasteur Dr
    Stanford, CA 94305
    Phone+1 650-723-4000

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2004 - 2006
  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2002 - 2004
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1998 - 2002
  • Hannover Medical School
    Hannover Medical SchoolClass of 1996

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2004 - 2025
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Twice‐Weekly Ixazomib in Combination with Lenalidomide‐Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma  
    Myo Htut, Michaela Liedtke, Stephen D Smith, Craig C Hofmeister, Rachid Baz, Paul G Richardson, Cara A Rosenbaum, David H Vesole, Ajai Chari, Jesus G Berdeja, Noopur Raje, British Journal of Haematology

Abstracts/Posters

  • Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Blinatumomab
    Michaela Liedtke, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Results of the Phase 3 VITAL Study of NEOD001 (Birtamimab) Plus Standard of Care in Patients with Light Chain (AL) Amyloidosis Suggest Survival Benefit for Mayo Stage ...
    Michaela Liedtke, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • SWOG 1312 Final Results: A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemi...
    Michaela Liedtke, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • A Panoply of Immunotherapies for Adult B-Lineage Acute Lymphocytic Leukemia 
    60th American Society of Hematology Annual Meeting - 12/3/2018
  • A Panoply of Immunotherapies for Adult B-Lineage Acute Lymphocytic Leukemia 
    60th American Society of Hematology Annual Meeting - 12/1/2018

Authored Content

  • Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-lineage Acute Lymphoblastic Leukemia in Measurable Residual Disease Negative Remission: Results from the ECOG-ACRIN E1910 Randomized Phase III National Cooperative Clinical Trials Network TrialDecember 2022

Press Mentions

  • FDA Approves Stanford Medicine-Developed Drug That Treats Rare Heart Disease
    FDA Approves Stanford Medicine-Developed Drug That Treats Rare Heart DiseaseNovember 27th, 2024
  • Venetoclax Induces Deep Hematologic Remissions in T(11;14) relapsed/refractory AL Amyloidosis
    Venetoclax Induces Deep Hematologic Remissions in T(11;14) relapsed/refractory AL AmyloidosisJanuary 11th, 2021
  • Another Milestone in the JACC Family of Journals: First Issue of JACC: CardioOncology Released
    Another Milestone in the JACC Family of Journals: First Issue of JACC: CardioOncology ReleasedOctober 18th, 2019
  • Join now to see all

Professional Memberships